[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Impact Factor 2022: 1.4
Cite Score 2022: 2.1
SJR 2022: 0.347
SNIP 2022: 0.545
Publication Charge
►Publication Fee
In Press
 In Press Articles
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 14, Issue 4 (Autumn 2023) ::
Caspian J Intern Med 2023, 14(4): 710-719 Back to browse issues page
Burden of prostate cancer and relationship with the human development index (HDI) in the in Asia: A study Global Burden disease in 2019
Elham Goodarzi , Fazlollah Fathollahi , Zaher Khazaei
Nutritional Health Research Center, school of Medicine, Lorestan University of Medical Sciences, khoramabad, Iran , f.fathollahi1984@gmail.com
Abstract:   (1467 Views)

Background: Prostate cancer (PC) ranks as the second most commonly diagnosed neoplasia and the fifth cause of death in men with cancer, with an increasing trend in incidence. The aim of this study was to investigate the epidemiological situation of prostate cancer and relationship with the human development index (HDI) in the Asian continent.
Methods: All accessible data sources from the 2019 Global Burden of Disease study were used to estimate the prevalence, mortality and disability-adjusted life years and burden prostate cancer in Asia from 1990 to 2019. We estimated all-cause and cause-specific mortality, years of life lost (YLLs), years lived with disability (YLDs) and disability-adjusted life-years (DALYs). All estimates were presented as counts and age-standardized rates per 100 000 population, with uncertainty intervals (UIs). Concentration Index analysis and Concentration Curve were used to determine the relationship between Prostate cancer burden and human development index.
Results: The highest incidence of prostate cancer in Asia in 2019 is Japan (90.5 per 100,000) and the highest mortality rate is Georgia (27.87 per 100,000). The highest DALY, YLL and YLD of prostate cancer is Georgia. The results showed that the percentage of changes in the incidence in 1990-2019 was positive in all countries of the Asian continent except for Afghanistan and Kyrgyzstan. The results of the concentration index showed that the incidence and mortality of prostate cancer is more concentrated in countries with a high HDI level. Examining the DALY, YLL and YLD index also showed the value of concentration index, which shows that DALY, YLL and YLD of prostate cancer are more concentrated in countries with high HDI level.
Conclusion: Given that the incidence, mortality and burden of prostate cancer are increasing in most Asian countries and are mostly concentrated in the HDI drawers, obtaining accurate estimates in these countries to prepare for the potential change in public health burden due to this disease which is very important.


Keywords: Key words: Prostate cancer, Inequality, Incidence, Mortality, Disease burden
Full-Text [PDF 995 kb]   (352 Downloads)    
Type of Study: Original Article | Subject: statistics
Received: 2022/10/15 | Accepted: 2023/02/25 | Published: 2023/09/6
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Goodarzi E, Fathollahi F, Khazaei Z. Burden of prostate cancer and relationship with the human development index (HDI) in the in Asia: A study Global Burden disease in 2019. Caspian J Intern Med 2023; 14 (4) :710-719
URL: http://caspjim.com/article-1-3702-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 14, Issue 4 (Autumn 2023) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.06 seconds with 39 queries by YEKTAWEB 4642